查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1862504

牛疫苗：全球市场份额和排名、总收入和需求预测（2025-2031 年）

Cattle Vaccine - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
出版日期: | 出版商: QYResearch | 英文 101 Pages | 商品交期: 2-3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2024 年全球牛疫苗市场规模预计为 16.8 亿美元，预计到 2031 年将达到 25.76 亿美元，在预测期（2025-2031 年）内复合年增长率为 6.4%。

牛疫苗是一种旨在帮助牛和牛对特定感染疾病产生免疫力的生物製药。

这些疫苗含有减毒、灭活或灭活的病原体（或其部分成分，例如蛋白质或毒素），能够刺激牛的免疫系统识别并抵抗疾病，而不会引起疾病本身。 2024年，全球牛疫苗产量达到约1.6亿支，全球平均市场价格约为每支10.5美元。

全球爆发的牛传染性疾病，如口蹄疫、牛呼吸道复合征、布氏桿菌症和牛病毒性腹泻，导致疫苗接种率上升。这些疾病会对畜牧业生产造成巨大的生产力和经济损失，因此疫苗接种是牛管理的重要组成部分。

亚太地区和拉丁美洲等地对优质牛肉和乳製品的需求不断增长，促使农民投资疫苗，以维持牛生产力和产品安全。

许多地区（例如欧盟、南美部分地区、印度）都实施了政府补贴或强制性的牛疫苗接种计划，以控制地方性疾病并稳定市场。

为提高疗效和减少副作用，基于重组DNA、次单位疫苗和mRNA的兽用疫苗的研发正在加速进行。

由于多病原体疫苗可以降低人力成本，并减轻动物在接种过程中的压力，因此这类疫苗越来越受欢迎。

尤其在开发中国家，耐热疫苗可以减少对低温运输物流的依赖，这点尤其重要。

本报告旨在按地区/国家、类型和销售管道对全球牛疫苗市场进行全面分析，重点关注总销售额、市场份额和主要企业的排名。

牛疫苗市场规模、估算和预测。报告采用定量和定性分析相结合的方法，帮助读者制定业务/成长策略，评估市场竞争格局，分析自身在当前市场中的地位，并就牛疫苗市场做出明智的商业决策。

市场区隔

公司

  • Merck Animal Health
  • Zoetis
  • Boehringer Ingelheim
  • Ceva
  • Zoetis
  • Elanco Animal Health
  • Indian Immunologicals
  • Cambridge Technologies
  • Vaxxinova
  • Jinyu Bio-Technolog
  • China Animal Husbandry Industry
  • Tecon Biology

按类型分類的细分市场

  • 减毒活病毒疫苗
  • 灭活疫苗
  • 其他的

销售管道细分

  • 政府竞标
  • 市场销售

按地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太地区
    • 中国
    • 日本
    • 韩国
    • 东南亚
    • 印度
    • 澳洲
    • 亚太其他地区
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 荷兰
    • 北欧国家
    • 其他欧洲
  • 拉丁美洲
    • 墨西哥
    • 巴西
    • 其他拉丁美洲
  • 中东和非洲
    • 土耳其
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 其他中东和非洲地区

The global market for Cattle Vaccine was estimated to be worth US$ 1680 million in 2024 and is forecast to a readjusted size of US$ 2576 million by 2031 with a CAGR of 6.4% during the forecast period 2025-2031.

A cattle vaccine is a biological preparation designed to help cattle (both beef and dairy) develop immunity against specific infectious diseases.

It contains weakened, killed, or inactivated pathogens (or parts of them, such as proteins or toxins) that stimulate the cow's immune system to recognize and fight the disease without causing the disease itself. In 2024, global cattle vaccines production reached approximately 160 million units , with an average global market price of around US$ 10.5 per unit.

Global outbreaks of infectious bovine diseases-such as Foot-and-Mouth Disease (FMD), Bovine Respiratory Disease Complex (BRDC), Brucellosis, and Bovine Viral Diarrhea (BVD)-are increasing vaccination adoption rates. These diseases can cause massive productivity and economic losses in the livestock industry, making preventive vaccination an essential part of herd management.

Increasing demand for high-quality beef and dairy products, especially in Asia-Pacific and Latin America, is pushing farmers to invest in vaccines to maintain herd productivity and product safety.

Many regions (e.g., EU, parts of South America, India) implement government-subsidized or mandatory cattle vaccination programs to control endemic diseases, ensuring market stability.

Development of recombinant DNA vaccines, subunit vaccines, and mRNA-based veterinary vaccines is accelerating, improving efficacy and reducing adverse reactions.

Multi-disease vaccines are gaining popularity for reducing labor costs and stress on animals during administration.

Especially important for developing countries, thermostable vaccines reduce dependency on cold chain logistics.

This report aims to provide a comprehensive presentation of the global market for Cattle Vaccine, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Cattle Vaccine by region & country, by Type, and by Sales Channel.

The Cattle Vaccine market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cattle Vaccine.

Market Segmentation

By Company

  • Merck Animal Health
  • Zoetis
  • Boehringer Ingelheim
  • Ceva
  • Zoetis
  • Elanco Animal Health
  • Indian Immunologicals
  • Cambridge Technologies
  • Vaxxinova
  • Jinyu Bio-Technolog
  • China Animal Husbandry Industry
  • Tecon Biology

Segment by Type

  • Live Attenuated Vaccine
  • Inactivated Vaccine
  • Others

Segment by Sales Channel

  • Government Bidding
  • Market Sales

By Region

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Netherlands
    • Nordic Countries
    • Rest of Europe
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of MEA

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Cattle Vaccine company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Sales Channel, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Revenue of Cattle Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Revenue of Cattle Vaccine in country level. It provides sigmate data by Type, and by Sales Channel for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

Table of Contents

1 Market Overview

  • 1.1 Cattle Vaccine Product Introduction
  • 1.2 Global Cattle Vaccine Market Size Forecast (2020-2031)
  • 1.3 Cattle Vaccine Market Trends & Drivers
    • 1.3.1 Cattle Vaccine Industry Trends
    • 1.3.2 Cattle Vaccine Market Drivers & Opportunity
    • 1.3.3 Cattle Vaccine Market Challenges
    • 1.3.4 Cattle Vaccine Market Restraints
  • 1.4 Assumptions and Limitations
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Competitive Analysis by Company

  • 2.1 Global Cattle Vaccine Players Revenue Ranking (2024)
  • 2.2 Global Cattle Vaccine Revenue by Company (2020-2025)
  • 2.3 Key Companies Cattle Vaccine Manufacturing Base Distribution and Headquarters
  • 2.4 Key Companies Cattle Vaccine Product Offered
  • 2.5 Key Companies Time to Begin Mass Production of Cattle Vaccine
  • 2.6 Cattle Vaccine Market Competitive Analysis
    • 2.6.1 Cattle Vaccine Market Concentration Rate (2020-2025)
    • 2.6.2 Global 5 and 10 Largest Companies by Cattle Vaccine Revenue in 2024
    • 2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cattle Vaccine as of 2024)
  • 2.7 Mergers & Acquisitions, Expansion

3 Segmentation by Type

  • 3.1 Introduction by Type
    • 3.1.1 Live Attenuated Vaccine
    • 3.1.2 Inactivated Vaccine
    • 3.1.3 Others
  • 3.2 Global Cattle Vaccine Sales Value by Type
    • 3.2.1 Global Cattle Vaccine Sales Value by Type (2020 VS 2024 VS 2031)
    • 3.2.2 Global Cattle Vaccine Sales Value, by Type (2020-2031)
    • 3.2.3 Global Cattle Vaccine Sales Value, by Type (%) (2020-2031)

4 Segmentation by Sales Channel

  • 4.1 Introduction by Sales Channel
    • 4.1.1 Government Bidding
    • 4.1.2 Market Sales
  • 4.2 Global Cattle Vaccine Sales Value by Sales Channel
    • 4.2.1 Global Cattle Vaccine Sales Value by Sales Channel (2020 VS 2024 VS 2031)
    • 4.2.2 Global Cattle Vaccine Sales Value, by Sales Channel (2020-2031)
    • 4.2.3 Global Cattle Vaccine Sales Value, by Sales Channel (%) (2020-2031)

5 Segmentation by Region

  • 5.1 Global Cattle Vaccine Sales Value by Region
    • 5.1.1 Global Cattle Vaccine Sales Value by Region: 2020 VS 2024 VS 2031
    • 5.1.2 Global Cattle Vaccine Sales Value by Region (2020-2025)
    • 5.1.3 Global Cattle Vaccine Sales Value by Region (2026-2031)
    • 5.1.4 Global Cattle Vaccine Sales Value by Region (%), (2020-2031)
  • 5.2 North America
    • 5.2.1 North America Cattle Vaccine Sales Value, 2020-2031
    • 5.2.2 North America Cattle Vaccine Sales Value by Country (%), 2024 VS 2031
  • 5.3 Europe
    • 5.3.1 Europe Cattle Vaccine Sales Value, 2020-2031
    • 5.3.2 Europe Cattle Vaccine Sales Value by Country (%), 2024 VS 2031
  • 5.4 Asia Pacific
    • 5.4.1 Asia Pacific Cattle Vaccine Sales Value, 2020-2031
    • 5.4.2 Asia Pacific Cattle Vaccine Sales Value by Region (%), 2024 VS 2031
  • 5.5 South America
    • 5.5.1 South America Cattle Vaccine Sales Value, 2020-2031
    • 5.5.2 South America Cattle Vaccine Sales Value by Country (%), 2024 VS 2031
  • 5.6 Middle East & Africa
    • 5.6.1 Middle East & Africa Cattle Vaccine Sales Value, 2020-2031
    • 5.6.2 Middle East & Africa Cattle Vaccine Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

  • 6.1 Key Countries/Regions Cattle Vaccine Sales Value Growth Trends, 2020 VS 2024 VS 2031
  • 6.2 Key Countries/Regions Cattle Vaccine Sales Value, 2020-2031
  • 6.3 United States
    • 6.3.1 United States Cattle Vaccine Sales Value, 2020-2031
    • 6.3.2 United States Cattle Vaccine Sales Value by Type (%), 2024 VS 2031
    • 6.3.3 United States Cattle Vaccine Sales Value by Sales Channel, 2024 VS 2031
  • 6.4 Europe
    • 6.4.1 Europe Cattle Vaccine Sales Value, 2020-2031
    • 6.4.2 Europe Cattle Vaccine Sales Value by Type (%), 2024 VS 2031
    • 6.4.3 Europe Cattle Vaccine Sales Value by Sales Channel, 2024 VS 2031
  • 6.5 China
    • 6.5.1 China Cattle Vaccine Sales Value, 2020-2031
    • 6.5.2 China Cattle Vaccine Sales Value by Type (%), 2024 VS 2031
    • 6.5.3 China Cattle Vaccine Sales Value by Sales Channel, 2024 VS 2031
  • 6.6 Japan
    • 6.6.1 Japan Cattle Vaccine Sales Value, 2020-2031
    • 6.6.2 Japan Cattle Vaccine Sales Value by Type (%), 2024 VS 2031
    • 6.6.3 Japan Cattle Vaccine Sales Value by Sales Channel, 2024 VS 2031
  • 6.7 South Korea
    • 6.7.1 South Korea Cattle Vaccine Sales Value, 2020-2031
    • 6.7.2 South Korea Cattle Vaccine Sales Value by Type (%), 2024 VS 2031
    • 6.7.3 South Korea Cattle Vaccine Sales Value by Sales Channel, 2024 VS 2031
  • 6.8 Southeast Asia
    • 6.8.1 Southeast Asia Cattle Vaccine Sales Value, 2020-2031
    • 6.8.2 Southeast Asia Cattle Vaccine Sales Value by Type (%), 2024 VS 2031
    • 6.8.3 Southeast Asia Cattle Vaccine Sales Value by Sales Channel, 2024 VS 2031
  • 6.9 India
    • 6.9.1 India Cattle Vaccine Sales Value, 2020-2031
    • 6.9.2 India Cattle Vaccine Sales Value by Type (%), 2024 VS 2031
    • 6.9.3 India Cattle Vaccine Sales Value by Sales Channel, 2024 VS 2031

7 Company Profiles

  • 7.1 Merck Animal Health
    • 7.1.1 Merck Animal Health Profile
    • 7.1.2 Merck Animal Health Main Business
    • 7.1.3 Merck Animal Health Cattle Vaccine Products, Services and Solutions
    • 7.1.4 Merck Animal Health Cattle Vaccine Revenue (US$ Million) & (2020-2025)
    • 7.1.5 Merck Animal Health Recent Developments
  • 7.2 Zoetis
    • 7.2.1 Zoetis Profile
    • 7.2.2 Zoetis Main Business
    • 7.2.3 Zoetis Cattle Vaccine Products, Services and Solutions
    • 7.2.4 Zoetis Cattle Vaccine Revenue (US$ Million) & (2020-2025)
    • 7.2.5 Zoetis Recent Developments
  • 7.3 Boehringer Ingelheim
    • 7.3.1 Boehringer Ingelheim Profile
    • 7.3.2 Boehringer Ingelheim Main Business
    • 7.3.3 Boehringer Ingelheim Cattle Vaccine Products, Services and Solutions
    • 7.3.4 Boehringer Ingelheim Cattle Vaccine Revenue (US$ Million) & (2020-2025)
    • 7.3.5 Boehringer Ingelheim Recent Developments
  • 7.4 Ceva
    • 7.4.1 Ceva Profile
    • 7.4.2 Ceva Main Business
    • 7.4.3 Ceva Cattle Vaccine Products, Services and Solutions
    • 7.4.4 Ceva Cattle Vaccine Revenue (US$ Million) & (2020-2025)
    • 7.4.5 Ceva Recent Developments
  • 7.5 Zoetis
    • 7.5.1 Zoetis Profile
    • 7.5.2 Zoetis Main Business
    • 7.5.3 Zoetis Cattle Vaccine Products, Services and Solutions
    • 7.5.4 Zoetis Cattle Vaccine Revenue (US$ Million) & (2020-2025)
    • 7.5.5 Zoetis Recent Developments
  • 7.6 Elanco Animal Health
    • 7.6.1 Elanco Animal Health Profile
    • 7.6.2 Elanco Animal Health Main Business
    • 7.6.3 Elanco Animal Health Cattle Vaccine Products, Services and Solutions
    • 7.6.4 Elanco Animal Health Cattle Vaccine Revenue (US$ Million) & (2020-2025)
    • 7.6.5 Elanco Animal Health Recent Developments
  • 7.7 Indian Immunologicals
    • 7.7.1 Indian Immunologicals Profile
    • 7.7.2 Indian Immunologicals Main Business
    • 7.7.3 Indian Immunologicals Cattle Vaccine Products, Services and Solutions
    • 7.7.4 Indian Immunologicals Cattle Vaccine Revenue (US$ Million) & (2020-2025)
    • 7.7.5 Indian Immunologicals Recent Developments
  • 7.8 Cambridge Technologies
    • 7.8.1 Cambridge Technologies Profile
    • 7.8.2 Cambridge Technologies Main Business
    • 7.8.3 Cambridge Technologies Cattle Vaccine Products, Services and Solutions
    • 7.8.4 Cambridge Technologies Cattle Vaccine Revenue (US$ Million) & (2020-2025)
    • 7.8.5 Cambridge Technologies Recent Developments
  • 7.9 Vaxxinova
    • 7.9.1 Vaxxinova Profile
    • 7.9.2 Vaxxinova Main Business
    • 7.9.3 Vaxxinova Cattle Vaccine Products, Services and Solutions
    • 7.9.4 Vaxxinova Cattle Vaccine Revenue (US$ Million) & (2020-2025)
    • 7.9.5 Vaxxinova Recent Developments
  • 7.10 Jinyu Bio-Technolog
    • 7.10.1 Jinyu Bio-Technolog Profile
    • 7.10.2 Jinyu Bio-Technolog Main Business
    • 7.10.3 Jinyu Bio-Technolog Cattle Vaccine Products, Services and Solutions
    • 7.10.4 Jinyu Bio-Technolog Cattle Vaccine Revenue (US$ Million) & (2020-2025)
    • 7.10.5 Jinyu Bio-Technolog Recent Developments
  • 7.11 China Animal Husbandry Industry
    • 7.11.1 China Animal Husbandry Industry Profile
    • 7.11.2 China Animal Husbandry Industry Main Business
    • 7.11.3 China Animal Husbandry Industry Cattle Vaccine Products, Services and Solutions
    • 7.11.4 China Animal Husbandry Industry Cattle Vaccine Revenue (US$ Million) & (2020-2025)
    • 7.11.5 China Animal Husbandry Industry Recent Developments
  • 7.12 Tecon Biology
    • 7.12.1 Tecon Biology Profile
    • 7.12.2 Tecon Biology Main Business
    • 7.12.3 Tecon Biology Cattle Vaccine Products, Services and Solutions
    • 7.12.4 Tecon Biology Cattle Vaccine Revenue (US$ Million) & (2020-2025)
    • 7.12.5 Tecon Biology Recent Developments

8 Industry Chain Analysis

  • 8.1 Cattle Vaccine Industrial Chain
  • 8.2 Cattle Vaccine Upstream Analysis
    • 8.2.1 Key Raw Materials
    • 8.2.2 Raw Materials Key Suppliers
    • 8.2.3 Manufacturing Cost Structure
  • 8.3 Midstream Analysis
  • 8.4 Downstream Analysis (Customers Analysis)
  • 8.5 Sales Model and Sales Channels
    • 8.5.1 Cattle Vaccine Sales Model
    • 8.5.2 Sales Channel
    • 8.5.3 Cattle Vaccine Distributors

9 Research Findings and Conclusion

10 Appendix

  • 10.1 Research Methodology
    • 10.1.1 Methodology/Research Approach
      • 10.1.1.1 Research Programs/Design
      • 10.1.1.2 Market Size Estimation
      • 10.1.1.3 Market Breakdown and Data Triangulation
    • 10.1.2 Data Source
      • 10.1.2.1 Secondary Sources
      • 10.1.2.2 Primary Sources
  • 10.2 Author Details
  • 10.3 Disclaimer

List of Tables

  • Table 1. Cattle Vaccine Market Trends
  • Table 2. Cattle Vaccine Market Drivers & Opportunity
  • Table 3. Cattle Vaccine Market Challenges
  • Table 4. Cattle Vaccine Market Restraints
  • Table 5. Global Cattle Vaccine Revenue by Company (2020-2025) & (US$ Million)
  • Table 6. Global Cattle Vaccine Revenue Market Share by Company (2020-2025)
  • Table 7. Key Companies Cattle Vaccine Manufacturing Base Distribution and Headquarters
  • Table 8. Key Companies Cattle Vaccine Product Type
  • Table 9. Key Companies Time to Begin Mass Production of Cattle Vaccine
  • Table 10. Global Cattle Vaccine Companies Market Concentration Ratio (CR5 and HHI)
  • Table 11. Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cattle Vaccine as of 2024)
  • Table 12. Mergers & Acquisitions, Expansion Plans
  • Table 13. Global Cattle Vaccine Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
  • Table 14. Global Cattle Vaccine Sales Value by Type (2020-2025) & (US$ Million)
  • Table 15. Global Cattle Vaccine Sales Value by Type (2026-2031) & (US$ Million)
  • Table 16. Global Cattle Vaccine Sales Market Share in Value by Type (2020-2025)
  • Table 17. Global Cattle Vaccine Sales Market Share in Value by Type (2026-2031)
  • Table 18. Global Cattle Vaccine Sales Value by Sales Channel: 2020 VS 2024 VS 2031 (US$ Million)
  • Table 19. Global Cattle Vaccine Sales Value by Sales Channel (2020-2025) & (US$ Million)
  • Table 20. Global Cattle Vaccine Sales Value by Sales Channel (2026-2031) & (US$ Million)
  • Table 21. Global Cattle Vaccine Sales Market Share in Value by Sales Channel (2020-2025)
  • Table 22. Global Cattle Vaccine Sales Market Share in Value by Sales Channel (2026-2031)
  • Table 23. Global Cattle Vaccine Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
  • Table 24. Global Cattle Vaccine Sales Value by Region (2020-2025) & (US$ Million)
  • Table 25. Global Cattle Vaccine Sales Value by Region (2026-2031) & (US$ Million)
  • Table 26. Global Cattle Vaccine Sales Value by Region (2020-2025) & (%)
  • Table 27. Global Cattle Vaccine Sales Value by Region (2026-2031) & (%)
  • Table 28. Key Countries/Regions Cattle Vaccine Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
  • Table 29. Key Countries/Regions Cattle Vaccine Sales Value, (2020-2025) & (US$ Million)
  • Table 30. Key Countries/Regions Cattle Vaccine Sales Value, (2026-2031) & (US$ Million)
  • Table 31. Merck Animal Health Basic Information List
  • Table 32. Merck Animal Health Description and Business Overview
  • Table 33. Merck Animal Health Cattle Vaccine Products, Services and Solutions
  • Table 34. Revenue (US$ Million) in Cattle Vaccine Business of Merck Animal Health (2020-2025)
  • Table 35. Merck Animal Health Recent Developments
  • Table 36. Zoetis Basic Information List
  • Table 37. Zoetis Description and Business Overview
  • Table 38. Zoetis Cattle Vaccine Products, Services and Solutions
  • Table 39. Revenue (US$ Million) in Cattle Vaccine Business of Zoetis (2020-2025)
  • Table 40. Zoetis Recent Developments
  • Table 41. Boehringer Ingelheim Basic Information List
  • Table 42. Boehringer Ingelheim Description and Business Overview
  • Table 43. Boehringer Ingelheim Cattle Vaccine Products, Services and Solutions
  • Table 44. Revenue (US$ Million) in Cattle Vaccine Business of Boehringer Ingelheim (2020-2025)
  • Table 45. Boehringer Ingelheim Recent Developments
  • Table 46. Ceva Basic Information List
  • Table 47. Ceva Description and Business Overview
  • Table 48. Ceva Cattle Vaccine Products, Services and Solutions
  • Table 49. Revenue (US$ Million) in Cattle Vaccine Business of Ceva (2020-2025)
  • Table 50. Ceva Recent Developments
  • Table 51. Zoetis Basic Information List
  • Table 52. Zoetis Description and Business Overview
  • Table 53. Zoetis Cattle Vaccine Products, Services and Solutions
  • Table 54. Revenue (US$ Million) in Cattle Vaccine Business of Zoetis (2020-2025)
  • Table 55. Zoetis Recent Developments
  • Table 56. Elanco Animal Health Basic Information List
  • Table 57. Elanco Animal Health Description and Business Overview
  • Table 58. Elanco Animal Health Cattle Vaccine Products, Services and Solutions
  • Table 59. Revenue (US$ Million) in Cattle Vaccine Business of Elanco Animal Health (2020-2025)
  • Table 60. Elanco Animal Health Recent Developments
  • Table 61. Indian Immunologicals Basic Information List
  • Table 62. Indian Immunologicals Description and Business Overview
  • Table 63. Indian Immunologicals Cattle Vaccine Products, Services and Solutions
  • Table 64. Revenue (US$ Million) in Cattle Vaccine Business of Indian Immunologicals (2020-2025)
  • Table 65. Indian Immunologicals Recent Developments
  • Table 66. Cambridge Technologies Basic Information List
  • Table 67. Cambridge Technologies Description and Business Overview
  • Table 68. Cambridge Technologies Cattle Vaccine Products, Services and Solutions
  • Table 69. Revenue (US$ Million) in Cattle Vaccine Business of Cambridge Technologies (2020-2025)
  • Table 70. Cambridge Technologies Recent Developments
  • Table 71. Vaxxinova Basic Information List
  • Table 72. Vaxxinova Description and Business Overview
  • Table 73. Vaxxinova Cattle Vaccine Products, Services and Solutions
  • Table 74. Revenue (US$ Million) in Cattle Vaccine Business of Vaxxinova (2020-2025)
  • Table 75. Vaxxinova Recent Developments
  • Table 76. Jinyu Bio-Technolog Basic Information List
  • Table 77. Jinyu Bio-Technolog Description and Business Overview
  • Table 78. Jinyu Bio-Technolog Cattle Vaccine Products, Services and Solutions
  • Table 79. Revenue (US$ Million) in Cattle Vaccine Business of Jinyu Bio-Technolog (2020-2025)
  • Table 80. Jinyu Bio-Technolog Recent Developments
  • Table 81. China Animal Husbandry Industry Basic Information List
  • Table 82. China Animal Husbandry Industry Description and Business Overview
  • Table 83. China Animal Husbandry Industry Cattle Vaccine Products, Services and Solutions
  • Table 84. Revenue (US$ Million) in Cattle Vaccine Business of China Animal Husbandry Industry (2020-2025)
  • Table 85. China Animal Husbandry Industry Recent Developments
  • Table 86. Tecon Biology Basic Information List
  • Table 87. Tecon Biology Description and Business Overview
  • Table 88. Tecon Biology Cattle Vaccine Products, Services and Solutions
  • Table 89. Revenue (US$ Million) in Cattle Vaccine Business of Tecon Biology (2020-2025)
  • Table 90. Tecon Biology Recent Developments
  • Table 91. Key Raw Materials Lists
  • Table 92. Raw Materials Key Suppliers Lists
  • Table 93. Cattle Vaccine Downstream Customers
  • Table 94. Cattle Vaccine Distributors List
  • Table 95. Research Programs/Design for This Report
  • Table 96. Key Data Information from Secondary Sources
  • Table 97. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Cattle Vaccine Product Picture
  • Figure 2. Global Cattle Vaccine Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
  • Figure 3. Global Cattle Vaccine Sales Value (2020-2031) & (US$ Million)
  • Figure 4. Cattle Vaccine Report Years Considered
  • Figure 5. Global Cattle Vaccine Players Revenue Ranking (2024) & (US$ Million)
  • Figure 6. The 5 and 10 Largest Companies in the World: Market Share by Cattle Vaccine Revenue in 2024
  • Figure 7. Cattle Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
  • Figure 8. Live Attenuated Vaccine Picture
  • Figure 9. Inactivated Vaccine Picture
  • Figure 10. Others Picture
  • Figure 11. Global Cattle Vaccine Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
  • Figure 12. Global Cattle Vaccine Sales Value Market Share by Type, 2024 & 2031
  • Figure 13. Product Picture of Government Bidding
  • Figure 14. Product Picture of Market Sales
  • Figure 15. Global Cattle Vaccine Sales Value by Sales Channel (2020 VS 2024 VS 2031) & (US$ Million)
  • Figure 16. Global Cattle Vaccine Sales Value Market Share by Sales Channel, 2024 & 2031
  • Figure 17. North America Cattle Vaccine Sales Value (2020-2031) & (US$ Million)
  • Figure 18. North America Cattle Vaccine Sales Value by Country (%), 2024 VS 2031
  • Figure 19. Europe Cattle Vaccine Sales Value, (2020-2031) & (US$ Million)
  • Figure 20. Europe Cattle Vaccine Sales Value by Country (%), 2024 VS 2031
  • Figure 21. Asia Pacific Cattle Vaccine Sales Value, (2020-2031) & (US$ Million)
  • Figure 22. Asia Pacific Cattle Vaccine Sales Value by Region (%), 2024 VS 2031
  • Figure 23. South America Cattle Vaccine Sales Value, (2020-2031) & (US$ Million)
  • Figure 24. South America Cattle Vaccine Sales Value by Country (%), 2024 VS 2031
  • Figure 25. Middle East & Africa Cattle Vaccine Sales Value, (2020-2031) & (US$ Million)
  • Figure 26. Middle East & Africa Cattle Vaccine Sales Value by Country (%), 2024 VS 2031
  • Figure 27. Key Countries/Regions Cattle Vaccine Sales Value (%), (2020-2031)
  • Figure 28. United States Cattle Vaccine Sales Value, (2020-2031) & (US$ Million)
  • Figure 29. United States Cattle Vaccine Sales Value by Type (%), 2024 VS 2031
  • Figure 30. United States Cattle Vaccine Sales Value by Sales Channel (%), 2024 VS 2031
  • Figure 31. Europe Cattle Vaccine Sales Value, (2020-2031) & (US$ Million)
  • Figure 32. Europe Cattle Vaccine Sales Value by Type (%), 2024 VS 2031
  • Figure 33. Europe Cattle Vaccine Sales Value by Sales Channel (%), 2024 VS 2031
  • Figure 34. China Cattle Vaccine Sales Value, (2020-2031) & (US$ Million)
  • Figure 35. China Cattle Vaccine Sales Value by Type (%), 2024 VS 2031
  • Figure 36. China Cattle Vaccine Sales Value by Sales Channel (%), 2024 VS 2031
  • Figure 37. Japan Cattle Vaccine Sales Value, (2020-2031) & (US$ Million)
  • Figure 38. Japan Cattle Vaccine Sales Value by Type (%), 2024 VS 2031
  • Figure 39. Japan Cattle Vaccine Sales Value by Sales Channel (%), 2024 VS 2031
  • Figure 40. South Korea Cattle Vaccine Sales Value, (2020-2031) & (US$ Million)
  • Figure 41. South Korea Cattle Vaccine Sales Value by Type (%), 2024 VS 2031
  • Figure 42. South Korea Cattle Vaccine Sales Value by Sales Channel (%), 2024 VS 2031
  • Figure 43. Southeast Asia Cattle Vaccine Sales Value, (2020-2031) & (US$ Million)
  • Figure 44. Southeast Asia Cattle Vaccine Sales Value by Type (%), 2024 VS 2031
  • Figure 45. Southeast Asia Cattle Vaccine Sales Value by Sales Channel (%), 2024 VS 2031
  • Figure 46. India Cattle Vaccine Sales Value, (2020-2031) & (US$ Million)
  • Figure 47. India Cattle Vaccine Sales Value by Type (%), 2024 VS 2031
  • Figure 48. India Cattle Vaccine Sales Value by Sales Channel (%), 2024 VS 2031
  • Figure 49. Cattle Vaccine Industrial Chain
  • Figure 50. Cattle Vaccine Manufacturing Cost Structure
  • Figure 51. Channels of Distribution (Direct Sales, and Distribution)
  • Figure 52. Bottom-up and Top-down Approaches for This Report
  • Figure 53. Data Triangulation
  • Figure 54. Key Executives Interviewed